
Agios Pharmaceuticals
#4833
Rank
$1.93B
Marketcap
United States
Country

Dr. Bruce D. Car DACVP, Ph.D. (Consultant)
Dr. Sarah Gheuens M.D., Ph.D. (Chief Medical Officer and Head of R&D)
Ms. Richa Poddar (Chief Commercial Officer)
Summary
History
Agios Pharmaceuticals was founded in 2007 and made its debut on the NASDAQ in July 2013. Its research and development program has advanced rapidly, and the company soon established itself as a leader in cancer metabolism and inborn errors of metabolism.
Mission
Vision
Key Team
Dr. Craig B. Thompson M.D. (Co-Founder & Chairman of Scientific Advisory Board)
Mr. Brian M. Goff M.B.A. (CEO & Director)
Ms. Cecilia Jones (Chief Financial Officer)
Dr. Lewis Clayton Cantley Ph.D. (Co-Founder & Member of Scientific Advisory Board)
Dr. Tak Wah Mak D.Sc., FRSC, Ph.D. (Co-Founder & Member of Scientific Advisory Board)
Dr. Shin-San Su Ph.D. (Co-Founder & Member of Scientific Advisory Board)
Mr. T. J. Washburn Jr. (Principal Accounting Officer)
Recognition and Awards
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Dr. Bruce D. Car DACVP, Ph.D. (Consultant)
Dr. Sarah Gheuens M.D., Ph.D. (Chief Medical Officer and Head of R&D)
Ms. Richa Poddar (Chief Commercial Officer)
